Bart Heeg
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Psychiatry and Mental health top 5%
- Schizophrenia research and treatment
Papers in
- Hematology 36
- Multiple Myeloma Research and Treatments 25
- Chronic Myeloid Leukemia Treatments 9
- Oncology 18
- Co-authors
- Ben A. van Hout (11 shared papers)Erik Buskens (6 shared papers)Mahmoud Hashim (18 shared papers)Ben van Hout (8 shared papers)Maarten J. Postma (13 shared papers)Meletios Α. Dimopoulos (13 shared papers)Annette Lam (17 shared papers)Jianming He (9 shared papers)
- Journals
- Value in Health (25 papers)Blood (13 papers)PharmacoEconomics (7 papers)Journal of Clinical Oncology (6 papers)Current Medical Research and Opinion (5 papers)
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
Bart Heeg
94 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 91
- Hematology 377
- Psychiatry and Mental health 171
- Oncology 202
- Economics and Econometrics 198
- Family Practice 11
Countries citing papers authored by Bart Heeg
This map shows the geographic impact of Bart Heeg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Heeg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Heeg more than expected).
Fields of papers citing papers by Bart Heeg
This network shows the impact of papers produced by Bart Heeg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Heeg. The network helps show where Bart Heeg may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart Heeg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 239 | |
| 2 | 2005 | 55 | |
| 3 | 2005 | 44 | |
| 4 | 2008 | 41 | |
| 5 | 2005 | 40 | |
| 6 | 2023 | 39 | |
| 7 | 2010 | 39 | |
| 8 | 2009 | 36 | |
| 9 | 2015 | 32 | |
| 10 | 2015 | 30 | |
| 11 | 2009 | 26 | |
| 12 | 2021 | 24 | |
| 13 | 2007 | 22 | |
| 14 | 2019 | 22 | |
| 15 | 2008 | 22 | |
| 16 | 2021 | 21 | |
| 17 | 2017 | 21 | |
| 18 | 2010 | 19 | |
| 19 | 2007 | 19 | |
| 20 | 2008 | 16 |
About Bart Heeg
Bart Heeg is a scholar working on Hematology, Oncology, Economics and Econometrics, Molecular Biology and Statistics and Probability, having authored 104 papers that have together received 1.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (25 papers), Health Systems, Economic Evaluations, Quality of Life (16 papers), Statistical Methods in Clinical Trials (12 papers), Schizophrenia research and treatment (10 papers), Chronic Myeloid Leukemia Treatments (9 papers), Protein Degradation and Inhibitors (7 papers), Prostate Cancer Treatment and Research (6 papers) and Chronic Lymphocytic Leukemia Research (6 papers). The work is most often cited by research in Hematology (377 citations), Psychiatry and Mental health (171 citations), Oncology (202 citations), Economics and Econometrics (198 citations) and Family Practice (11 citations). Bart Heeg has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Ben A. van Hout, Erik Buskens, Mahmoud Hashim, Ben van Hout, Maarten J. Postma, Meletios Α. Dimopoulos, Annette Lam, Jianming He, Margarita Kulakova and Frank de Charro. Their work appears in journals such as Value in Health, Blood, PharmacoEconomics, Journal of Clinical Oncology and Current Medical Research and Opinion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.